Latest Rosuvastatin Stories
All six trials met primary efficacy endpoint TARRYTOWN, N.Y. and PARIS, Nov. 19, 2014 /PRNewswire/ -- Regeneron Pharmaceuticals, Inc.
- All six trials met primary efficacy endpoint - PARIS AND TARRYTOWN, N.Y., Nov. 19, 2014 /PRNewswire/ -- Sanofi and Regeneron Pharmaceuticals, Inc.
Lawsuit Funding Network has secured investors to assist victims who have developed Type-II Diabetes while either taking Lipitor or Crestor. Lake Zurich IL (PRWEB)
The just-filed lawsuit was filed by a group of consumers who allege that the maker and distributor of Crestor, prescribed to lower cholesterol levels, allegedly hid information on the drug’s
The Firm is evaluating Lipitor lawsuits on behalf of patients who allegedly developed Type 2 diabetes due to their use of the statin medication. New York, New
THOUSAND OAKS, Calif., May 13, 2014 /PRNewswire/ -- Amgen (NASDAQ:AMGN) today announced the publication of data from the Phase 3 LAPLACE-2 (LDL-C Assessment with PCSK9 MonoclonaL
Susquehanna Health (SH) Cardiologist Dr.
Data From Two Separate Phase 3 Studies of Evolocumab (AMG 145), a PCSK9 Inhibitor, Presented in Late-Breaking Clinical Trials Session at ACC.14 - Data Add to the Three Pivotal Studies Presented Yesterday THOUSAND
Federal litigation involving Pfizer's cholesterol-lowering drug Lipitor has been consolidated before a single judge in South Carolina. (PRWEB) March 25,
New Published Study Reveals BergaMet(TM) Added to Statins Enhances Lipid Lowering and Artery Health DENVER, Feb.
- The act of sweetening by admixture of some saccharine substance.